Khalid Islam - Aug 9, 2024 Form 4 Insider Report for Gain Therapeutics, Inc. (GANX)

Signature
/s/ Khalid Islam
Stock symbol
GANX
Transactions as of
Aug 9, 2024
Transactions value $
$49,940
Form type
4
Date filed
8/12/2024, 05:23 PM
Previous filing
Jun 26, 2024
Next filing
Aug 19, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GANX Common Stock Purchase $49.9K +50K $1.00 50K Aug 9, 2024 Direct F2
holding GANX Common Stock 881K Aug 9, 2024 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Reporting Person is the ultimate shareholder of 1 MM & 1 PP AG, which is the direct beneficial owner of the securities.
F2 The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $0.9814 to $1.00 per share, inclusive. The reporting person undertakes to provide to Gain Therapeutics, Inc., any security holder of Gain Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.